MedMira China Partner Places Order for 400,000 Rapid HIV Tests

MedMira Inc., a Halifax-based developer and marketer of rapid diagnostic technology and solutions, announced that the company’s strategic partner in China, Triplex International Biosciences Co., Ltd., has placed an initial order for 400,000 MedMira rapid HIV tests. This order follows the completion of a critical evaluation recently completed by the China National Center for Disease Control for all the imported and domestic rapid HIV tests. This is the first major order from Triplex since they began market development activities for MedMira in China.